Permanent access to the portal system for cellular transplantation using an implantable port device
- 1 September 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 10 (9) , 1213-1215
- https://doi.org/10.1002/lt.20228
Abstract
A novel application of the implantable Port-a-Cath (PAC) system is described in the context of cellular transplantation. A silicone catheter was inserted in a collateral branch of the portal vein and connected to a port device positioned subcutaneously on the left thoracic cage. This permanent vascular access allowed iterative intraportal infusions of allogenic hepatocytes without the need of repeated transhepatic catheterization of the portal vein. Using this technique, repeated infusions of cryopreserved and / or fresh hepatocytes were successfully carried out in 3 children with inborn errors of liver metabolism, with the aim of progressively providing a sufficient mass of transplanted liver cells to stabilize the metabolic condition of the patients. We suggest that this technique might also be valuable in pancreatic islet cell transplantation. (Liver Transpl 2004;10:1213-1215.)Keywords
This publication has 6 references indexed in Scilit:
- Technical aspects of islet preparation and transplantationTransplant International, 2003
- Hepatocyte transplantation in a 4-year-old girl with peroxisomal biogenesis disease: technique, safety, and metabolic follow-up1Transplantation, 2003
- Hepatocyte transplantation as a treatment for glycogen storage disease type 1aThe Lancet, 2002
- Islet transplantation: Present clinical situation and future aspectsExperimental and Clinical Endocrinology & Diabetes, 2001
- Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive RegimenNew England Journal of Medicine, 2000
- Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte TransplantationNew England Journal of Medicine, 1998